Replies to post #122595 on Biotech Values

[oldberkeley]

TDLP Files for Bankruptcy

On April 14, National Football League Hall of Famer and network sports analyst Lynn Swann resigned as a Transdel director

Lynn was great with transdermal formulations that minimize adverse gastrointestinal effects, but was a tad weak on pharmacokinetic sub-studies of Phase 3 trials.

Probably why they let him go.

[mcbio]

A couple of years ago, this was one of the most pumped biotech companies on iHub: e.g. #msg-42212620. The company’s phase-3 trial failed, but TDLP called it a big success (#msg-42212740); in my experience, this is a pretty good prognostic indicator that a company will eventually go bust.

LOL That was an epic exchange you had back then with 'righty'. Probably not the most appropriate of screen names for that particular poster.